Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series. [electronic resource]
Producer: 20151026Description: 44-7 p. digitalISSN:- 0022-1058
- Anticoagulants -- administration & dosage
- Antithrombin III -- administration & dosage
- Antithrombins -- administration & dosage
- Cardiopulmonary Bypass -- adverse effects
- Coated Materials, Biocompatible -- administration & dosage
- Drug Combinations
- Drug Resistance
- Female
- Hemorrhage -- chemically induced
- Heparin -- administration & dosage
- Humans
- Male
- Middle Aged
- Recombinant Proteins -- administration & dosage
- Thrombosis -- prevention & control
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.